Legal & General Group
DMTX

Legal & General Group’s Dimension Therapeutics, Inc DMTX Stock Holding History

Legal & General Group’s Portfolio DMTX Stock Details DMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-709
Closed -$1K – 3476
2017
Q1 		$1K Hold
709
– – ﹤0.01% 3266
2016
Q4 		$3K Buy
+709
New +$3.77K ﹤0.01% 3278

Other funds holding DMTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Legal & General Group's DMTX Position: Q2 2017 in Review

Legal & General Group sold out of Dimension Therapeutics, Inc (DMTX) in Q2 2017, closing a stake of 709 shares — an estimated $1K sold.

Legal & General Group first reported a position in DMTX in Q4 2016 and held it in 2 quarters. The position peaked at $3K in Q4 2016. 35 funds tracked by Wall St. Rank hold DMTX as of Q2 2017.

  • Legal & General Group reported no remaining Dimension Therapeutics, Inc position as of Q2 2017 after selling out during the quarter.
  • Legal & General Group sold 709 Dimension Therapeutics, Inc shares in Q2 2017, an estimated $1K.
  • Legal & General Group first reported a position in Dimension Therapeutics, Inc in Q4 2016 and held it in 2 quarters.
  • Legal & General Group's Dimension Therapeutics, Inc position peaked at $3K in Q4 2016.
  • 35 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q2 2017.

Based on Legal & General Group's 13F filing for Q2 2017, filed 3 Aug 2017.